title: [NEWLY-DIAGNOSED CHRONIC KIDNEY DISEASE IN PATIENTS OF A THERAPEUTIC CLINIC: THE ROLE OF GFR CALCULATION BY THE CKD-EPI FORMULA].
abstract: OBJECTIVE
  to estimate the prevalence of newly-diagnosed chronic kidney disease (CKD) and its risk factors in patients of a therapeutic clinic, to evaluate the importance of GFR calculation using the CKD-EPI formula. Materials and methods: the study included 275 patients (275 (31.1%) men and 610 (68.9%) women) aged 18-89 (mean 59.5 13.95) years. GFR of 60ml/min/l.73 m3 or signs of kidney lesions were diagnosed as CKD. Possible risk factors of CKD were elucidated based on the results of a questionnaire that provided information on complaints, metabolic disorders, family histoty compliance with a healthy lifestyle. Arterial pressure and serum creatinine level were measured, BMI and GFR calculated in all patients.
  
  
  RESULTS
  Medical histories of 58% of the 885 patients contained signs of CKD. Among the remaining 372 (42%) ones, 7.2% had proteinuria and 20.1% GFR of 60ml/min/1. 73/m3. The prevalence of newly diagnosed CKD was 27.3%. The use of the CKD-EPI formula allowed to diagnose CKD in 18% of the patients having the serum creatinine level within normal values. The overall prevalence of CKD in the study group was 14%.
  
  
  CONCLUSIONS
  the prevalence of newly diagnosed CKD in patients of a therapeutic clinic was 2 7.3%. The use of the CKD-EPI formula facilitates diagnostics of CKD.
authors.forename: S S
authors.initials: SS
authors.lastname: Nagaitseva
authors.forename: M Yu
authors.initials: MY
authors.lastname: Shvetsov
authors.forename: L P
authors.initials: LP
authors.lastname: Lukshina
authors.forename: S V
authors.initials: SV
authors.lastname: Burba
authors.forename: A G
authors.initials: AG
authors.lastname: Garpishchenko
authors.forename: A N
authors.initials: AN
authors.lastname: Gerasimov
authors.forename: E M
authors.initials: EM
authors.lastname: Shilov
mesh_terms: D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D000886:Anthropometry / Q000379:methods; D003920:Diabetes Mellitus / Q000453:epidemiology*; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D006301:Health Services Needs and Demand; D006801:Humans; D006973:Hypertension / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000453:epidemiology*; D011314:Preventive Health Services; D011379:Prognosis; D051436:Renal Insufficiency, Chronic / Q000175:diagnosis / Q000453:epidemiology; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D012426:Russia / Q000453:epidemiology
chemical_list: D000700:Analgesics